| Literature DB >> 33572385 |
Farah Tamirou1, Frédéric A Houssiau1.
Abstract
Lupus nephritis (LN) is a frequent and severe manifestation of systemic lupus erythematosus. The main goal of the management of LN is to avoid chronic kidney disease (CKD). Current treatment strategies remain unsatisfactory in terms of complete renal response, prevention of relapses, CKD, and progression to end-stage kidney disease. To improve the prognosis of LN, recent data suggest that we should (i) modify our treat-to-target approach by including, in addition to a clinical target, a pathological target and (ii) switch from conventional sequential therapy to combination therapy. Here, we also review the results of recent controlled randomized trials.Entities:
Keywords: combination therapy; lupus nephritis; repeat kidney biopsy; treat-to-target approach
Year: 2021 PMID: 33572385 PMCID: PMC7916202 DOI: 10.3390/jcm10040670
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241